Navigation Links
Scientists ID New Gene Regions Linked to Type 2 Diabetes
Date:8/13/2012

MONDAY, Aug. 13 (HealthDay News) -- Scientists have identified 10 new regions of DNA linked to type 2 diabetes, bringing the total number of genes and gene regions associated with the disease to more than 60.

Type 2 diabetes occurs when the body does not produce enough insulin and does not respond effectively to the insulin it does produce. As a result, glucose levels in the blood can increase unchecked. Uncontrolled diabetes can lead to a number of health complications, including heart disease, stroke, nerve damage and blindness.

The international team of researchers said their findings may help experts develop treatments for the condition.

"The 10 gene regions we have shown to be associated with type 2 diabetes are taking us nearer a biological understanding of the disease," said the study's principal investigator Mark McCarthy of the Wellcome Trust Centre for Human Genetics at the University of Oxford, in a university news release. "It is hard to come up with new drugs for diabetes without first having an understanding of which biological processes in the body to target. This work is taking us closer to that goal."

The study, led by researchers from the University of Oxford, the Broad Institute of Harvard and MIT, and the University of Michigan, investigated common genetic variations in DNA that may be linked to type 2 diabetes.

The investigators examined the DNA of nearly 35,000 people with type 2 diabetes and roughly 115,000 people without the disease and found the new gene regions where DNA changes could be linked to people's risk for diabetes. Two of these regions showed different effects depending on gender. One was associated with greater risk for the disease in men, while the other was linked to increased risk in women.

A pattern in the type of genes linked to type 2 diabetes also emerged from the study.

"By looking at all 60 or so gene regions together we can look for signatures of the type of genes that influence the risk of type 2 diabetes," McCarthy said. "We see genes involved in controlling the process of cell growth, division and aging, particularly those that are active in the pancreas where insulin is produced. We see genes involved in pathways through which the body's fat cells can influence biological processes elsewhere in the body. And we see a set of transcription factor genes -- genes that help control what other genes are active."

The study authors said they are continuing their investigation of the genetic changes behind type 2 diabetes by fully sequencing patients' DNA.

"Not only will we be able to look for signals we've so far missed, but we will also be able to pinpoint which individual DNA change is responsible," McCarthy said. "These genome sequencing studies will really help us push forward towards a more complete biological understanding of diabetes."

The study was published online Aug. 12 in Nature Genetics.

More information

The American Diabetes Association has more about the genetics of diabetes.

-- Mary Elizabeth Dallas

SOURCE: University of Oxford, news release, Aug. 12, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Scientists solving the mystery of human consciousness
2. Scientists uncover multiple faces of deadly breast cancer
3. Scientists identify major source of cells defense against oxidative stress
4. Scientists tailor cell surface targeting system to hit organelle ZIP codes
5. Scientists rewrite rulebook on breast cancer in landmark global study
6. Warwick scientists uncover how checkpoint proteins bind chromosomes
7. NIH scientists link quickly spreading gene to Asian MRSA epidemic
8. Joslin scientists identify important mechanism that affects the aging process
9. Scripps Research scientists show how memory B cells stay in class to fight different infections
10. Scientists Map Melanomas Genome
11. A*STAR scientists discover switch to boost anti-viral response to fight infectious diseases
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists ID New Gene Regions Linked to Type 2 Diabetes
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: